ATE295178T1 - Azellulärer pertussis-impfstoff, der ein diphtheriae- und tetanus-toxoid enthält - Google Patents

Azellulärer pertussis-impfstoff, der ein diphtheriae- und tetanus-toxoid enthält

Info

Publication number: ATE295178T1
Authority: AT; Austria
Prior art keywords: acecellular; diphtheriae; tetanus toxoid; vaccine containing; pertussis vaccine
Prior art date: 1996-11-07

Application number

AT02075821T

Other languages

English (en)

Inventor

Patrick Florent

Jean Stephenne

Christian Vandecasserie

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-07

Filing date

1997-11-04

Publication date

2005-05-15

1997-11-04 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE295178T1 publication Critical patent/ATE295178T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Virology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AT02075821T 1996-11-07 1997-11-04 Azellulärer pertussis-impfstoff, der ein diphtheriae- und tetanus-toxoid enthält ATE295178T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9623233.5A GB9623233D0 (en)	1996-11-07	1996-11-07	Vaccine composition

Publications (1)

Publication Number	Publication Date
ATE295178T1 true ATE295178T1 (de)	2005-05-15

Family

ID=10802615

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT97950137T ATE222773T1 (de)	1996-11-07	1997-11-04	Azellulärer pertussis-impfstoff, der ein diphtherie-toxoid und ein tetanus-toxoid enthält
AT02075821T ATE295178T1 (de)	1996-11-07	1997-11-04	Azellulärer pertussis-impfstoff, der ein diphtheriae- und tetanus-toxoid enthält

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT97950137T ATE222773T1 (de)	1996-11-07	1997-11-04	Azellulärer pertussis-impfstoff, der ein diphtherie-toxoid und ein tetanus-toxoid enthält

Country Status (30)

Country	Link
EP (2)	EP1240905B3 (de)
JP (1)	JP3980652B2 (de)
KR (1)	KR100518044B1 (de)
CN (1)	CN1130226C (de)
AR (1)	AR011509A1 (de)
AT (2)	ATE222773T1 (de)
AU (1)	AU710475B2 (de)
BR (2)	BRPI9712917B8 (de)
CA (1)	CA2271008C (de)
CO (1)	CO4910171A1 (de)
CY (2)	CY2407B1 (de)
CZ (1)	CZ295954B6 (de)
DE (3)	DE69715031T2 (de)
DK (2)	DK0941117T3 (de)
ES (2)	ES2182131T3 (de)
GB (1)	GB9623233D0 (de)
HK (1)	HK1050473B (de)
HU (1)	HU224126B1 (de)
IL (1)	IL129530A (de)
LU (1)	LU91183I2 (de)
NO (2)	NO320186B1 (de)
NZ (1)	NZ335384A (de)
PL (1)	PL188460B1 (de)
PT (2)	PT941117E (de)
SA (1)	SA98181128B1 (de)
SI (2)	SI0941117T1 (de)
TR (1)	TR199900979T2 (de)
TW (1)	TW471971B (de)
WO (1)	WO1998019702A1 (de)
ZA (1)	ZA979984B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1004314A1 (de) *	1998-11-26	2000-05-31	Pasteur Merieux MSD	T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
KR100374813B1 (ko) *	2000-04-07	2003-03-03	녹십자백신 주식회사	디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
KR100401423B1 (ko) *	2001-01-10	2003-10-17	주식회사 엘지생명과학	혼합 백신의 제조 방법
JP5007425B2 (ja) *	2006-01-30	2012-08-22	財団法人ヒューマンサイエンス振興財団	百日咳ワクチンの安全性評価方法
GB0616306D0 (en) *	2006-08-16	2006-09-27	Novartis Ag	Vaccines
GB0822633D0 (en) *	2008-12-11	2009-01-21	Novartis Ag	Formulation
US9950062B2 (en)	2009-09-02	2018-04-24	Glaxosmithkline Biologicals Sa	Compounds and compositions as TLR activity modulators
JP2013538217A (ja)	2010-09-01	2013-10-10	ノバルティスアーゲー	不溶性金属塩への免疫増強物質の吸着
CN103533954B (zh)	2011-03-02	2015-09-09	诺华股份有限公司	含较低剂量的抗原和/或佐剂的联合疫苗
CN102363041A (zh) *	2011-11-17	2012-02-29	成都欧林生物科技股份有限公司	不含防腐剂疫苗的制作工艺
CA2866406A1 (en)	2012-03-08	2013-09-12	Novartis Ag	Adjuvanted formulations of booster vaccines
CN102793915B (zh) *	2012-07-25	2013-10-23	天津康希诺生物技术有限公司	一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en)	2012-08-06	2014-02-06	Glaxosmithkline Biologicals, S.A.	Novel method
SG11201500573RA (en)	2012-08-06	2015-02-27	Glaxosmithkline Biolog Sa	Method for eliciting in infants an immune response against rsv and b. pertussis
CN103100081A (zh) *	2012-12-26	2013-05-15	天津康希诺生物技术有限公司	一种多价联合疫苗
BR112015021523A8 (pt)	2013-03-08	2021-06-29	Crucell Holland Bv	composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
SG11201600709TA (en)	2013-08-05	2016-02-26	Glaxosmithkline Biolog Sa	Combination immunogenic compositions
CN114748616A (zh) *	2022-05-23	2022-07-15	中国医学科学院医学生物学研究所	一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) *	2023-01-10	2024-04-19	康希诺生物股份公司	一种百日咳毒素脱毒方法及无细胞百白破联合疫苗
CN119524117B (zh) *	2025-01-23	2025-09-23	康希诺生物股份公司	免疫原性组合物、百白破联合疫苗及其制备方法和应用
CN119548620B (zh) *	2025-01-23	2025-09-12	康希诺生物股份公司	一种用于预防白喉、百日咳和破伤风的免疫原性组合物、疫苗及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI861417A0 (fi)	1985-04-15	1986-04-01	Endotronics Inc	Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en)	1985-11-26	1990-01-23	Phillips Petroleum Company	Yeast production of hepatitis B surface antigen
ZA88488B (en)	1987-01-30	1988-10-26	Smith Kline Rit	Hepatitis b virus surface antigens and hybrid antigens containing them
EP0304578B1 (de)	1987-06-22	2001-10-24	Medeva Holdings Bv	Hepatitis-B-Oberflächenantigen enthaltendes Peptid
DE3789866T2 (de)	1987-07-17	1994-09-22	Rhein Biotech Gesellschaft Fuer Neue Biotechnologische Prozesse Und Produkte Mbh, 40595 Duesseldorf	DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung.
DK0414374T3 (da)	1989-07-25	1998-03-09	Smithkline Beecham Biolog	Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf
GB9007024D0 (en)	1990-03-29	1990-05-30	Imperial College	Novel vaccine
JP3626996B2 (ja) *	1992-05-23	2005-03-09	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン

1996
- 1996-11-07 GB GBGB9623233.5A patent/GB9623233D0/en active Pending
1997
- 1997-11-04 SI SI9730394T patent/SI0941117T1/xx unknown
- 1997-11-04 PT PT97950137T patent/PT941117E/pt unknown
- 1997-11-04 TR TR1999/00979T patent/TR199900979T2/xx unknown
- 1997-11-04 NZ NZ335384A patent/NZ335384A/xx not_active IP Right Cessation
- 1997-11-04 AT AT97950137T patent/ATE222773T1/de active
- 1997-11-04 PT PT02075821T patent/PT1240905E/pt unknown
- 1997-11-04 WO PCT/EP1997/006180 patent/WO1998019702A1/en not_active Ceased
- 1997-11-04 BR BRPI9712917A patent/BRPI9712917B8/pt unknown
- 1997-11-04 AU AU53196/98A patent/AU710475B2/en not_active Expired
- 1997-11-04 ES ES97950137T patent/ES2182131T3/es not_active Expired - Lifetime
- 1997-11-04 HU HU9904287A patent/HU224126B1/hu active IP Right Grant
- 1997-11-04 IL IL12953097A patent/IL129530A/xx not_active IP Right Cessation
- 1997-11-04 EP EP02075821A patent/EP1240905B3/de not_active Expired - Lifetime
- 1997-11-04 JP JP52107098A patent/JP3980652B2/ja not_active Expired - Lifetime
- 1997-11-04 DE DE69715031T patent/DE69715031T2/de not_active Expired - Lifetime
- 1997-11-04 SI SI9730706T patent/SI1240905T1/xx unknown
- 1997-11-04 DK DK97950137T patent/DK0941117T3/da active
- 1997-11-04 DK DK02075821T patent/DK1240905T5/da active
- 1997-11-04 BR BR9712917-8A patent/BR9712917A/pt not_active IP Right Cessation
- 1997-11-04 CN CN97199491A patent/CN1130226C/zh not_active Expired - Lifetime
- 1997-11-04 CZ CZ19991640A patent/CZ295954B6/cs not_active IP Right Cessation
- 1997-11-04 KR KR10-1999-7004016A patent/KR100518044B1/ko not_active Expired - Lifetime
- 1997-11-04 ES ES02075821T patent/ES2240647T7/es active Active
- 1997-11-04 AT AT02075821T patent/ATE295178T1/de active
- 1997-11-04 CA CA002271008A patent/CA2271008C/en not_active Expired - Lifetime
- 1997-11-04 EP EP97950137A patent/EP0941117B1/de not_active Expired - Lifetime
- 1997-11-04 DE DE69733285T patent/DE69733285T3/de not_active Expired - Lifetime
- 1997-11-06 AR ARP970105177A patent/AR011509A1/es active IP Right Grant
- 1997-11-06 ZA ZA979984A patent/ZA979984B/xx unknown
- 1997-11-07 CO CO97065487A patent/CO4910171A1/es unknown
- 1997-12-24 TW TW086119712A patent/TW471971B/zh not_active IP Right Cessation
1998
- 1998-04-25 SA SA98181128A patent/SA98181128B1/ar unknown
1999
- 1999-05-04 NO NO19992156A patent/NO320186B1/no not_active IP Right Cessation
- 1999-05-05 PL PL97333127A patent/PL188460B1/pl unknown
2000
- 2000-03-10 HK HK03101055.7A patent/HK1050473B/en not_active IP Right Cessation
2004
- 2004-02-26 CY CY0400014A patent/CY2407B1/xx unknown
2005
- 2005-06-16 DE DE200512000046 patent/DE122005000046I1/de active Pending
- 2005-07-20 LU LU91183C patent/LU91183I2/fr unknown
2006
- 2006-04-25 NO NO2006005C patent/NO2006005I2/no unknown
- 2006-11-09 CY CY0600031A patent/CY2568B1/xx unknown

Also Published As

Publication number	Publication date
CY2407B1 (en)	2004-09-10
PL188460B1 (pl)	2005-02-28
CA2271008C (en)	2008-07-22
NO2006005I1 (no)	2006-05-08
CO4910171A1 (es)	2000-04-24
NO320186B1 (no)	2005-11-07
HUP9904287A3 (en)	2001-05-28
HK1050473A1 (en)	2003-06-27
ES2182131T3 (es)	2003-03-01
HK1050473B (en)	2006-03-03
DE69715031T2 (de)	2003-05-08
HUP9904287A1 (hu)	2000-04-28
BRPI9712917B8 (pt)	2021-05-25
CN1236321A (zh)	1999-11-24
ZA979984B (en)	1998-07-23
JP3980652B2 (ja)	2007-09-26
AU710475B2 (en)	1999-09-23
CY2568B1 (en)	2008-07-02
PT1240905E (pt)	2005-09-30
NO992156D0 (no)	1999-05-04
CA2271008A1 (en)	1998-05-14
EP1240905A1 (de)	2002-09-18
IL129530A (en)	2005-11-20
SI1240905T1 (en)	2005-10-31
NO2006005I2 (no)	2010-04-12
TR199900979T2 (xx)	1999-07-21
PL333127A1 (en)	1999-11-22
HU224126B1 (hu)	2005-05-30
HK1022638A1 (en)	2000-08-18
AR011509A1 (es)	2000-08-30
CN1130226C (zh)	2003-12-10
WO1998019702A1 (en)	1998-05-14
EP1240905B3 (de)	2009-08-26
ATE222773T1 (de)	2002-09-15
GB9623233D0 (en)	1997-01-08
PT941117E (pt)	2002-12-31
NO992156L (no)	1999-05-04
BRPI9712917B1 (pt)	2019-12-03
DE69715031D1 (de)	2002-10-02
ES2240647T7 (es)	2010-03-31
IL129530A0 (en)	2000-02-29
SA98181128B1 (ar)	2006-03-25
KR100518044B1 (ko)	2005-09-30
EP1240905B1 (de)	2005-05-11
CZ164099A3 (cs)	1999-10-13
ES2240647T3 (es)	2005-10-16
AU5319698A (en)	1998-05-29
DE69733285D1 (de)	2005-06-16
KR20000053092A (ko)	2000-08-25
DK0941117T3 (da)	2002-11-18
SI0941117T1 (en)	2002-12-31
DE69733285T2 (de)	2006-01-12
EP0941117A1 (de)	1999-09-15
TW471971B (en)	2002-01-11
BR9712917A (pt)	1999-12-07
DE69733285T3 (de)	2010-03-25
DK1240905T3 (da)	2005-07-18
JP2001503422A (ja)	2001-03-13
LU91183I2 (fr)	2005-09-20
EP0941117B1 (de)	2002-08-28
NZ335384A (en)	2000-10-27
DK1240905T5 (da)	2010-01-11
DE122005000046I1 (de)	2005-12-29
CZ295954B6 (cs)	2005-12-14

Publication	Publication Date	Title
DE69733285D1 (de)	2005-06-16	Azellulärer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enthält
FI972034A7 (fi)	1997-07-11	Polynukleotidi tuberkuloosirokote
FI953529L (fi)	1995-09-15	Rokotteita, jotka sisältävät gangliosidi-KLH-konjugaattia ja QS-21-ainetta
NO891513D0 (no)	1989-04-12	Fremgangsmaate og innretning for opphenting av en broennverktoey-/foeringsrammeanordning.
DE69511635D1 (de)	1999-09-30	Eine Walze
EP0474646A4 (en)	1992-10-21	Bordetella vaccines
BR9204365A (pt)	1993-05-11	Saco e metodo para fabricar um saco
HU912864D0 (en)	1992-01-28	Haemophylus paragallinarum vaccine
EP0427768A4 (en)	1991-11-21	Polypeptide pertussis toxin vaccine
GB8918206D0 (en)	1989-09-20	Tuberculosis vaccine
NO892997D0 (no)	1989-07-21	Bordetella pertussis vaksine.
EP0572670A4 (de)	1995-04-26	Polycaprolactonstapelfase und herstellung.
EP0918725A4 (de)	1999-11-17	Eine litze
FR2636353B1 (fr)	1991-06-14	Laineuse a cardes
EP0912193A4 (de)	2000-11-02	Impfstoff zur verhütung von streptokokken endocarditis
IE892369L (en)	1990-01-22	Bordetella pertussis vaccine
IL144200A0 (en)	2002-05-23	A polynucleotide tuberculosis vaccine
IL89798A0 (en)	1989-09-28	Key identification aid
FI880644A7 (fi)	1989-08-12	Menetelmä katteiden ja peitteiden paikallaan pitämiseksi.
IT9058805U1 (it)	1992-04-17	Chiodo a doppia testa.